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CASE REPORT Open Access
Incidental metastatic mediastinal atypical
carcinoid in a patient with parathyroid
adenoma: a case report
Zareen Kiran1*, Asma Ahmed1, Owais Rashid1, Saira Fatima2, Faizan Malik2, Saulat Fatimi3 and Mubassher Ikram4
Abstract
Background: Atypical carcinoid arising from the mediastinal tissue is a rare neuroendocrine tumor and an
association with parathyroid adenoma is very unusual. We report an unusual case of atypical carcinoid of
mediastinum with metastasis in a patient presenting with parathyroid adenoma, which is the first case to be
reported from Pakistan.
Case presentation: A 51-year-old Pakistani man was seen in postoperative intensive care after right
parathyroidectomy and mediastinal mass resection for the management of postoperative hypocalcaemia. He
had a background history of dyspnea. Examination was unremarkable. Preoperative laboratory evaluation
revealed a calcium level of 12.7 mg/dl, phosphate of 1.9 mg/dl, serum albumin of 4.8 g/dl, alkaline phosphate
of 94 U/L, and serum intact parathyroid hormone level 413.8 pg/ml. A technetium-99m sestamibi parathyroid
scan showed right parathyroid increased tracer uptake. Further workup revealed a large mediastinal mass
which was diagnosed as atypical carcinoid after Tru-Cut biopsy. He underwent right-sided parathyroidectomy
and resection of the mediastinal mass. The histopathology confirmed it to be a parathyroid adenoma and
atypical carcinoid tumor of his mediastinum with metastasis in his lymph node and parathyroid gland.
Somatostatin receptor scintigraphy revealed a well-defined focus in his left hypochondriac region consistent
with a somatostatin receptor scintigraphy-avid tumor. He was started on everolimus and planned for
octreotide therapy.
Conclusions: We describe an incidental finding of atypical carcinoid of the mediastinum in a patient
diagnosed as having parathyroid adenoma. Clinical manifestations of neuroendocrine syndromes are
challenging. Some tumors cluster in a non-classic description with other common neoplasms. They rarely
present in isolation, remain clinically silent, and need aggressive workup with the aid of imaging and
histopathology.
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Background
Primary neuroendocrine tumors of the mediastinum are
rare. They can arise from thymic or non-thymic tissue,
can be low to high grade and classified as well-
differentiated or poorly differentiated neoplasms [1].
Among the well-differentiated category, we still find the
terms “carcinoid” and “atypical” carcinoid in use in the
literature [2, 3]. Atypical thymic carcinoid, a rare type of
neuroendocrine tumor, has been described as a separate
entity [4] as well as in combination with multiple endo-
crine neoplasia (MEN) type 1 [5]; however, atypical carcin-
oid arising in the mediastinum is very rare [1]. Most of the
literature on neuroendocrine tumors is described in isola-
tion and no substantial data describe an association with
parathyroid adenoma from the South Asian region [6, 7].
We describe an incidentally diagnosed metastatic atypical
carcinoid from mediastinal tissue in a patient presenting
with parathyroid adenoma, which to the best of our know-
ledge is the first case reported from Pakistan.
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Case presentation
A 51-year-old Pakistani man with diabetes was seen in
postoperative care for hypocalcemia following parathy-
roidectomy of his parathyroid adenoma. He was a non-
tobacco smoker, with a history of bilateral pedal edema
for 1.5 months, and myalgia and dyspnea for less than 1
month. There was a history of renal stones treated with
lithotripsy 7 years earlier. His medications included
Mixtard-30 (human insulin), sitagliptin, metformin, and
furosemide. His family history was insignificant. On
examination he was well oriented and his vital signs
were stable. A general physical examination revealed
only mild pedal edema. A systemic examination was
unremarkable. Preoperative investigations showed a
calcium (Ca) level of 12.7 mg/dl, phosphate (PO4) 1.9
mg/dl, and serum albumin of 4.8g/dl; his alkaline phos-
phate 94 U/L and serum intact parathyroid hormone
(PTH) level was 413.8 pg/ml. His serum creatinine was
1.04 mg/dl and he had an estimated glomerular filtration
rate (eGFR) of 75.28 ml per minute/1.73m2. An ultra-
sound of his abdomen showed bilateral medullary
nephrocalcinosis. An ultrasound of his neck revealed
that his right thyroid lobe was mildly enlarged and both
lobes showed a few small scattered solid nodules less
than 10 mm. His right inferior parathyroid gland was
markedly enlarged measuring 3.9×1.3×2.3 cm. Thyroid
function tests were normal. A technetium-99m (99mTc)
sestamibi parathyroid scan was carried out, which
showed a focal area of intensely increased tracer uptake
in his right thyroid lobe, which after washout still
showed intense tracer accumulation with a probability of
parathyroid adenoma or hyperplasia in the right group
of parathyroid glands (Fig. 1). On further workup, a
chest X-ray revealed a left-sided mediastinal mass
(Fig. 2a). Computed tomography of his chest with con-
trast showed an anterior mediastinal mass measuring
142 mm in diameter showing calcification (Fig. 2b). He
underwent Tru-Cut biopsy of this mass and histopath-
ology revealed fibrocollagenous tissue showing sheets of
neoplastic cells. After immunohistochemical staining
and based on raised proliferative index (Ki-67 10%), this
tumor was classified as atypical carcinoid tumor. He was
planned for resection of this tumor as well as parathy-
roidectomy in a one-stage surgery.
He developed hypocalcaemia postoperatively which
was adequately treated. His postoperative PTH came
down to 45.90 pg/ml. The histopathology of the medias-
tinal tumor measuring 18×15×14 cm and level 5 medias-
tinal lymph node measuring 0.5×0.3 cm retrieved during
surgery revealed an encapsulated lesion comprising dif-
fuse sheets and nests of neoplastic cells, separated by
thick and thin fibrous bands. An occasional mitotic fig-
ure was seen: up to 2/10 to 3/10 high-power field (HPF).
In some areas the tumor cells formed rosette-like struc-
tures. Large areas of necrosis were seen along with
extensive homogenous, fibrotic areas (Fig. 3c). These
areas were negative for Congo red or Sirius red special
stains. An immunohistochemical examination showed
the same reactivity pattern as the Tru-Cut biopsy. Histo-
pathology of the parathyroid tissue showed fragmented
tissue, without cytological atypia, mitotic activity, peri-
neural invasion, indicating parathyroid adenoma (Fig. 3d).
Fig. 1 Technetium-99m sestamibi parathyroid scan. The scan shows focal area of increased uptake in right thyroid lobe
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There were clusters of neuroendocrine cells, suggestive
of involvement by mediastinal atypical carcinoid. A sec-
tion from his lymph node was also positive for tumor
metastasis. These features were consistent with atypical
carcinoid tumor with lymph node metastasis. His urin-
ary 5-hydroxyindoleacetic acid (5-HIAA) was only mildly
elevated: 7.9 mg/24 hours (2–7). His serum prolactin
level was 5.90 U/L (<23.8). Later, somatostatin receptor
scintigraphy (SRS) revealed a well-defined focus in his
left hypochondriac region between the inner border of
his spleen and his left upper renal pole, consistent with
SRS-avid tumor (Fig. 4). Another area of increased tracer
uptake was noted involving his right thyroid bed. He has
been started on everolimus and planned for octreotide
therapy. He is currently asymptomatic and recovering
well.
Discussion
Neuroendocrine tumors arising from the thymus itself
account for just 2 to 5% of primary thymic malignancies
[8]. Atypical carcinoid is even a rarer type of neuroendo-
crine tumor [3]. They mostly remain asymptomatic until
they metastasize at the time of presentation (66% to
lymph nodes from pulmonary origin) and behave as
aggressive tumors rather than slow growing carcinoids.
They are different from carcinoid tumors as they mostly
Fig. 2 Radiological findings of mediastinal mass. a Chest X-ray showing large left mediastinal mass. b Computed tomography of chest with contrast
showing left-sided radiodense mass with calcifications
Fig. 3 Histopathology of mediastinal mass and parathyroid tissue. a Immunohistochemical stain positive for chromogranin-A. b Mib-1 (Ki-67) positivity
in mediastinal mass. c Hematoxylin and eosin staining of the mediastinal mass showing diffuse sheets and nests of neoplastic cells, separated by thick
and thin fibrous bands. d Histologic findings of the parathyroid tissue without cytological atypia or mitotic activity favoring parathyroid adenoma
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Fig. 4 Somatostatin receptor imaging with technetium-99m hydrazinonicotinamide octreotide. Somatostatin receptor scintigraphy image revealed a
well-defined focus in left hypochondrium consistent with somatostatin receptor scintigraphy-avid tumor. Another area of increased tracer uptake of
moderate intensity involved the right thyroid bed
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arise in the foregut tissues such as bronchial epithelium
and thymus gland. Patients usually have normal levels of
serotonin and chromogranin-A in their blood and nor-
mal levels of 5-HIAA in their urine; however, they have
raised levels of serotonin and 5-hydroxytryptophan (5-
HTP) in their urine [1, 3, 9].
There is a case report of atypical carcinoid originating
from the thymus gland in the form of a mediastinal mass
in association with hypercalcemia which was found to be
due to parathyroid adenoma [4]. Another case report of
MEN 1 has shown ectopic parathyroid tissue in the me-
diastinal mass [10] and another has reported thymic car-
cinoid with atypical course in such patients [11];
however, very limited data are reported on the concomi-
tant presence of parathyroid adenoma and asymptomatic
metastatic mediastinal atypical carcinoid other than
thymus. A single study has described a clear distinction
between such a neuroendocrine tumor originating as
ectopic tissue in the mediastinum rather than from a
thymus gland [1]. Our patient’s histopathology did not
reveal any thymic tissue and has characteristic immuno-
histochemical staining for the neuroendocrine neo-
plasms, more specifically for atypical carcinoid tumor.
The presence of sheets of cells in the parathyroid tissue
(Fig. 3) of our patient presents the metastasis of atypical
carcinoid tumor from the mediastinal ectopic neuroen-
docrine cells, which is a rare entity that has not been de-
scribed before. Whether this can be the cause of
parathyroid adenoma and hyperparathyroidism in our
patient and what genetics could be involved is not much
known. Besides parathyroid gland, it has also metasta-
sized to lymph nodes, thyroid areas, and peripancreatic
areas. Our patient had no clinical stigmata of carcinoid
syndrome and has not had any airway obstructive dis-
ease (in view of large mediastinal mass). Further evalu-
ation for pituitary tumor in the form of imaging was not
possible due to financial limitations; besides, he did not
have any clinical features of Cushing’s syndrome or acro-
megaly. Thus, our patient had multiple endocrine disor-
ders with two neoplasms, of which one was aggressive
with a guarded prognosis. Such a clustering can be very
well explained as a variant of MEN syndromes and needs
genetic analysis, which is not available in our region.
Moreover, apart from everolimus therapy, which has
been shown to improve prognosis in a trial [12], the
octreotide avidity of the metastasis in our patient means
that our patient needs octreotide treatment as part of
ongoing care, which has limitations in a resource-poor
country.
Conclusions
We presented a case of metastatic mediastinal atypical
carcinoid in a patient with parathyroid adenoma, diag-
nosed incidentally during preoperative workup. The
unusual clustering of neuroendocrine tumors is being in-
creasingly reported in the literature, and patients with
hyperparathyroidism should be thoroughly investigated
to diagnose and treat other related tumors particularly
atypical carcinoid of mediastinum as it has a poor out-
come and limited treatment options.
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